SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.36+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mudcat who wrote (22929)7/8/1998 11:02:00 AM
From: jayhawk969  Read Replies (6) of 32384
 
Mudcat,

<Other companies have blockbusters, Lgnd has an
unproven pipeline, that is concentrating on small markets.>

Unproven pipeline, Yes. Concentrating on small markets, No. After one gets past Karposi's & CTCL the markets for breast cancer, prostate cancer, diabetes, etc. are huge.

<I think the street is smart enough to know if off label uses for Panretin are in the cards.>

Mudcat, you are part of the street, what is your take on off label use for Panretin?

J.D.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext